Visus Therapeutics appoints 6 executive leaders

Ophthalmic pharmaceutical company Visus Therapeutics introduced six new executives it has appointed to lead the company.

Advertisement

The six appointments are Tim Grinstead as COO; James Burke as vice president of research; Patrick Hughes, PhD, as vice president of pharmaceutical development; Lisa Simpson as vice president of clinical operations and compliance; Guru Sharma, OD, as director of ophthalmology and clinical development; and Alex Oh as vice president of intellectual property.

Visus Therapeutics is a clinical-stage company with offices in Seattle and Orange County, Calif.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.